XTLB
XTL Biopharmaceuticals
XTLB
XTLB
3 hedge funds and large institutions have $293K invested in XTL Biopharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$363 |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$52K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $241K | – | – | – |
|
|
2
Morgan Stanley
New York
| $52K | -$2.78K | -2,300 | -5% |
|
|
3
UBS Group
Zurich,
Switzerland
| $363 | +$363 | +300 | New |
|